Also from this source

You just read:

SillaJen Poster Presentation at 2018 GU ASCO Symposium Highlights New Clinical Data in RCC, Intravenous Delivery of Pexa-Vec, Oncolytic Immunotherapy

News provided by

SillaJen, Inc.

Feb 23, 2018, 09:00 EST